Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
09/17/14 Gilead (GILD) Simtuzumab for Pancreatic Cancer Subscribers Only Subscribers Only     Subscribers Only
09/17/14 Merck (MRK) Omarigliptin for Diabetes Mellitus, Type II Subscribers Only Subscribers Only     Subscribers Only
09/17/14 Impax (IPXL) Rytary for Parkinson's Disease (PD) Subscribers Only Subscribers Only     Subscribers Only
09/16/14 Flexion (FLXN) FX006 for Osteoarthritis Subscribers Only Subscribers Only     Subscribers Only
09/16/14 Oncolytics (ONCY) Reolysin for Pancreatic Cancer Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 09/18/14 Subscribers Only Subscribers Only Trial Data - Other
09/18/14 Subscribers Only Subscribers Only Regulatory - FDA Advisory Panel Meeting
09/18/14 Subscribers Only Subscribers Only Trial Data - Other
09/18/14 Subscribers Only Subscribers Only Trial Data - Updated Results
Now - 09/19/14 Subscribers Only Subscribers Only Company - Earnings Announcement